Delivery Order SPE2DX22D0010-SPE2D826FBQ21
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (Adderall) Extended Release Capsules, 5 milligrams, with a contract ceiling value of $4,076.90. The award was made on December 10, 2025, under a firm fixed price delivery order with an ultimate completion date of December 11, 2025. This non-competitive, non-set-aside contract represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Adderall tablets (10mg) under a firm fixed-price contract with a ceiling value of $9,584.53. This non-set-aside award represents a competitively awarded delivery order with an ultimate completion date of July 22, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,457.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Adderall XR 25 mg capsules (100-count units) with a ceiling value of $2,252.98. This is a firm fixed price delivery order with an ultimate completion date of December 12, 2025, and no set-aside designation was utilized. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,332.85 by the Medical Supply Chain, a defense-focused federal agency, on October 24, 2025, with an ultimate completion date of October 27, 2025. The contract covers the supply of Amphetamine Mix (Adderall) Extended Release Capsules 20mg, a controlled pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. The award is a firm fixed price delivery order with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,097.69. This non-set-aside delivery order is scheduled for completion by December 10, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of the company's extensive role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall XR 20 mg capsules (100 count) with a ceiling value of $18,892.20. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, represents a competitively awarded, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Adderall 10 mg tablets (100-count units) with a ceiling value of $4,902.64 and an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement. The vendor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Adderall XR capsules in 30mg dosage with a ceiling value of $1,089.44. This firm fixed-price delivery order, which is scheduled for completion by October 22, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,312.16 on December 1, 2025, for the supply of Adderall XR 30 mg capsules (100-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of December 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBQ21Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Amphetamine Mix (Adderall) extended-release capsules, 20mg, with a ceiling value of $2,292.80. This firm fixed-price delivery order, with an ultimate completion date of December 10, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a prime vendor for the Defense Health Agency and other federal healthcare systems, supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates consistent capability to fulfill diverse medical procurement requirements through competitive awards spanning therapeutic domains from specialty medications to vaccines and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 12/8/25 |